- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05179109
Robotic Versus Laparoscopic Surgery for Deep Endometriosis (ROBEndo)
May 11, 2023 updated by: Sari Koivurova, University of Oulu
Robotic Versus Laparoscopic Surgery for Severe Deep Endometriosis: a Prospective, Randomized, Controlled Trial
The objective of this study is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The objective of this prospective, randomized trial is to examine whether robot-assisted laparoscopy is superior compared to conventional laparoscopy as regards to patient outcome at 6, 12 and 24 months postoperatively, measured by questionnaires concerning the pain symptoms and disease-related quality-of life.
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anna M Terho, MD
- Phone Number: +35883153603
- Email: anna.terho@fimnet.fi
Study Contact Backup
- Name: Sari Koivurova, MD, PhD
- Phone Number: +35883153082
- Email: sari.koivurova@fimnet.fi
Study Locations
-
-
-
Oulu, Finland, 90220
- Recruiting
- Northern Ostrobothnia Hospital District
-
Contact:
- Koivurova
- Email: sari.koivurova@fimnet.fi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ASA (American Society of Anesthesiologists physical status classification) 1-3
- Diagnosed deep endometriosis (MRI)
- Patient has symptoms
- Operative treatment is indicated
- Patient is able to give informed consent
Exclusion Criteria:
- ASA > 3
- Recurring rectosigmoid endometriosis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Robot-assisted laparoscopy
Surgery for deep endometriosis using robot-assisted laparoscopy.
|
Minimally invasive surgery for severe deep endometriosis
|
Active Comparator: Conventional laparoscopy
Surgery for deep endometriosis using conventional laparoscopy.
|
Minimally invasive surgery for severe deep endometriosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NRS (Numeric rating scale) Score for pain
Time Frame: Immediately postoperatively (24 hours) and 6, 12 and 24 months postoperatively
|
The surgical outcome as regards to pain symptoms (NRS questionnaire), absolute scores and change from baseline for both study groups.
|
Immediately postoperatively (24 hours) and 6, 12 and 24 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraoperative measures
Time Frame: Up to 300 minutes (intraoperative)
|
Operation time (minutes), blood loss (ml), complications (classified according to Clavien-Dindo) for both study groups.
|
Up to 300 minutes (intraoperative)
|
Factors concerning ERAS (Enhanced recovery after surgery)
Time Frame: Up to 7 days (Hospital stay)
|
Nausea (yes/no), vomiting (yes/no), peroral intake (minutes from surgery), mobilization (minutes from surgery), bowel movement (minutes from surgery), time of discharge (hours after surgery), complications (classified according to Clavien-Dindo) for both study groups.
|
Up to 7 days (Hospital stay)
|
Cost
Time Frame: Primary hospital stay and 24 months, for both study groups.
|
Cost, euros.
|
Primary hospital stay and 24 months, for both study groups.
|
Complications
Time Frame: 30 days
|
Complications (classified according to Clavien-Dindo), readmissions to hospital.
|
30 days
|
Endometriosis-related quality-of-life
Time Frame: 6, 12 and 24 months
|
Quality-of-life questionnaire (EHP-30, Endometriosis-related health profile) described as absolute scores and change from the baseline.
Scale 0-100.
Score 0 equals the best outcome and score 100 equals the worst outcome.
|
6, 12 and 24 months
|
General 15 dimensional health-related quality-of-life questionnaire
Time Frame: 6, 12 and 24 months
|
Quality-of-life questionnaire (15D, general quality-of-life questionnaire) described as absolute scores and change from baseline for both study groups.
Scale 0-1.
Score 0 equals the worst outcome and score 1 equals the best outcome.
|
6, 12 and 24 months
|
Sexual quality-of-life questionnaire
Time Frame: 6, 12 and 24 months
|
Quality-of-life (FSFI, female sexual function index) described as absolute scores and change from baseline for both study groups.
Scale 2,0-36,0.
Score 2,0 equals the worst outcome and score 36,0 equals the best outcome.
|
6, 12 and 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sari Koivurova, MD, PhD, Oulu University Hospital, Department of Obstetrics and Gynecology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 3, 2022
Primary Completion (Anticipated)
December 31, 2025
Study Completion (Anticipated)
December 31, 2026
Study Registration Dates
First Submitted
December 7, 2021
First Submitted That Met QC Criteria
December 20, 2021
First Posted (Actual)
January 5, 2022
Study Record Updates
Last Update Posted (Actual)
May 15, 2023
Last Update Submitted That Met QC Criteria
May 11, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ROBtrial1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
Clinical Trials on Minimally invasive surgery
-
Istituto Clinico HumanitasFondazione Umberto VeronesiRecruiting
-
National Taiwan University HospitalCompletedColorectal Cancer | AdhesionTaiwan
-
October 6 UniversityCompleted
-
Tianjin Medical University Cancer Institute and...Harvard Medical School (HMS and HSDM); M.D. Anderson Cancer Center; Massachusetts... and other collaboratorsEnrolling by invitation
-
Yarmouk UniversityCompletedMinimally Invasive Surgery | Hydatid Disease | Spleen-Preserving Surgery | Echinococcus Granulosus InfectionJordan
-
Hospital del MarEnrolling by invitationGallbladder CancerSpain
-
University of Illinois at ChicagoRecruiting
-
Yonsei UniversityRecruiting
-
Radboud University Medical CenterDutch Heart Foundation; Penumbra Inc.CompletedIntracerebral Hemorrhage | Surgical Procedures, Minimally InvasiveNetherlands
-
Associazione Italiana per lo Studio del PancreasRecruiting